LON:ABC Abcam (ABC) Share Forecast, Price & News GBX 1,226 +123.00 (+11.15%) (As of 12/13/2022) Add Compare Share Share Today's Range 1,115▼ 1,25950-Day Range 1,226▼ 1,22652-Week Range 1,013.57▼ 1,760Volume6.37 million shsAverage Volume392,791 shsMarket Capitalization£2.81 billionP/E Ratio20,433.33Dividend Yield0.91%Price TargetN/A ProfileProfileChartCompetitorsInsider TradesHeadlinesOptions ChainProfileChartCompetitorsInsider TradesHeadlinesOptions Chain About Abcam (LON:ABC) StockAbcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.Read More Receive ABC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter. Email Address ABC Stock News HeadlinesMay 30, 2023 | finance.yahoo.comABCAM PLC: Statement on calling an Extraordinary General MeetingMay 26, 2023 | thetimes.co.ukAbcam faces wrath for move to America’s Nasdaq indexJune 7, 2023 | Vantage Point (Ad)Major Financial Crisis Could Hit AmericaSomething strange is happening in our financial system. UBS analysts predict over 50,000 retail locations may close soon. Retail giants like Walmart, Foot Locker, Bed Bath & Beyond, and Macy's are already downsizing their stores. Are you using the best technology to protect your money at all costs? May 23, 2023 | finance.yahoo.comHow Much Upside is Left in Abcam PLC Sponsored ADR (ABCM)? Wall Street Analysts Think 27.55%May 17, 2023 | msn.comAbcam founder Jonathan Milner calls for extraordinary general meetingMay 17, 2023 | markets.businessinsider.comAbcam PLC: Statement on potential Extraordinary General MeetingMay 17, 2023 | marketwatch.comNitrocellulose Membranes Market New Insight Report | 2023-2031May 17, 2023 | finance.yahoo.comABCAM PLC Result of Annual General MeetingJune 7, 2023 | Legacy Research (Affiliate) (Ad)“One-Stock Millionaire” IGNORES 99.9% of the MarketDuring the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.May 17, 2023 | msn.comAbcam Founder Seeks to Oust Chairman of $4 Billion BiotechMay 17, 2023 | finance.yahoo.comJonathan Milner Announces That He is Taking Steps to Call an Extraordinary General Meeting of Abcam ShareholdersMay 16, 2023 | marketwatch.comMammalian Polyclonal IgG Antibody Market Size 2023 – Industry Share, Growth Rate, and Forecast to 2029 – Polyclonal Antibody,Abcam PLCMay 16, 2023 | marketwatch.comImmunoprecipitation Market to Witness Growth Acceleration by Top Key Players – Thermo Fisher Scientific, Abcam plc, GenScript Biotech CorporationMay 16, 2023 | marketwatch.comHerpes Marker Testing Market Research | 2023-2030May 16, 2023 | marketwatch.comHygromycin B Market | Worldwide Industry Trends 2023-2030May 15, 2023 | marketwatch.comPaper Diagnostics Market Growth Forecast 2022-2030 Research Report | Abbott, Bio-Rad Laboratories, Siemens Healthcare, AbcamMay 15, 2023 | marketwatch.com2030, Tetracosactide Market ResearchMay 15, 2023 | marketwatch.comDiagnostic Antibodies Market Till 2030May 15, 2023 | marketwatch.comHuman VEGF Antibody Market Research & Future Success 2023-2030May 13, 2023 | marketwatch.comNon-Selective ELISA Kits Market: Trends, Recent Growth till 2030May 11, 2023 | msn.comAbcam Founder Ramps Up Board Seat Push at $4 Billion BiotechMay 10, 2023 | marketwatch.comSelisistat (EX-527) Market Projected to Reach Significant Growth Value by 2031May 9, 2023 | marketwatch.comDiagnostic Antibodies Market 2023, As Per The Latest Insights, With a Forecast PeriodMay 8, 2023 | marketwatch.comLuciferase Monoclonal Antibody Market Insights, Forecast to 2029 Market Size 2023-2031 Industrial Outlook by Absolute Reports | with [105 Pages]May 8, 2023 | finance.yahoo.comGlobal Reporter Gene Assay Market to Reach $11.5 Billion by 2030May 8, 2023 | marketwatch.comHuman Wound Healing Assay Kit Market by Section, Solution, Deployment mode, Size and Region 2023-2030May 8, 2023 | marketwatch.comDNA Methylation Detection Kit Market by Section, Solution, Deployment mode, Size and Region 2023-2030See More Headlines ABC Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Industry, Sector and Symbol Stock ExchangeLON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:ABC CUSIPN/A CIKN/A Webwww.abcam.com Phone+44-1223-696000FaxN/AEmployees1,650Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio20,433.33 Forward P/E RatioN/A P/E Growth1.57Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio31.60 Current Ratio1.27 Quick Ratio0.89 Sales & Book Value Annual Sales£350.40 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow24.07 Book ValueGBX 318.30 per share Price / BookN/AMiscellaneous Outstanding Shares229,272,000Free FloatN/AMarket Cap£2.81 billion OptionableOptionable BetaN/A Key ExecutivesMr. Alan Thomas Hirzel BS (Age 54)M.B.A., M.S., MBA, MS, CEO & Exec. Director Comp: $1.23MMr. Michael Shaun Baldock B.A. (Age 58)CFO & Director Comp: $881.14kMr. Mark DermodyInterim CIOJames StaveleyVP of Investor RelationsMarc PerkinsGen. Counsel & Company Sec.Emma SceatsSr. VP of Sales, Service & Bus. Devel.Mr. Nick SkinnerSr. VP of HRMr. Mark BushfieldSr. VP of Research & InnovationMs. Kirstie Speck BBusScHead of Consumer InsightsMs. Yvonne ChienSr. VP of Customer ExperienceMore ExecutivesKey CompetitorsBTGLON:BTGOxford Nanopore TechnologiesLON:ONTGenusLON:GNSUDG HealthcareLON:UDGIndiviorLON:INDVView All CompetitorsInsidersMichael BaldockSold 18,032 sharesTotal: £25.64 M ($1,422.00/share)View All Insider Transactions ABC Stock - Frequently Asked Questions What other stocks do shareholders of Abcam own? Based on aggregate information from My MarketBeat watchlists, some companies that other Abcam investors own include Hawkins (HWKN), CA (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), HSBC (HSBA), Royal Dutch Shell (RDSA) and Centrica (CNA). What is Abcam's stock symbol? Abcam trades on the London Stock Exchange (LON) under the ticker symbol "ABC." How do I buy shares of Abcam? Shares of ABC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. How much money does Abcam make? Abcam (LON:ABC) has a market capitalization of £0.00 and generates £350.40 million in revenue each year. How many employees does Abcam have? The company employs 1,650 workers across the globe. How can I contact Abcam? Abcam's mailing address is 330 Cambridge Science Park, CAMBRIDGE, CB4 0FL, United Kingdom. The official website for the company is www.abcam.com. The company can be reached via phone at +44-1223-696000. This page (LON:ABC) was last updated on 6/7/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abcam plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.